Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease
- PMID: 18830076
- PMCID: PMC3954509
- DOI: 10.1097/HCO.0b013e328312c2f5
Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease
Abstract
Purpose of review: This review is meant as a balanced summary of the current state of cardiac magnetic resonance (CMR) perfusion imaging in assessing alterations in myocardial blood flow due to coronary artery disease (CAD). We aim to provide first an accessible technical overview of first-pass CMR perfusion imaging and contrast it with other conventional perfusion imaging modalities, and then address the potential advantages of CMR for a qualitative assessment of perfusion defects, as well as quantitative blood flow measurements. Most recent results from clinical trials on the utility of CMR perfusion and novel directions will be explored.
Recent findings: Recent results of the first multicenter multivendor CMR perfusion study demonstrated superior diagnostic utility in detecting CAD by CMR compared with conventional nuclear single-photon emission computed tomography. Several large clinical trials provide additional evidence indicating the strong prognostic implications when CMR perfusion was performed in a clinical setting in patients with an intermediate clinical likelihood of CAD. A negative adenosine stress CMR perfusion study conferred a favorable 3-year prognosis towards nonfatal myocardial infarction or cardiac death.
Summary: CMR perfusion imaging during the first pass of gadolinium-based contrast agents has undergone many technical improvements and levels of clinical validation. Rapidly increasing clinical use worldwide over the last years in diagnosing chest pain syndromes supports the role of CMR in a comprehensive and efficient noninvasive assessment of altered myocardial physiology in CAD.
Figures




Similar articles
-
Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol.JACC Cardiovasc Imaging. 2009 Nov;2(11):1292-300. doi: 10.1016/j.jcmg.2009.05.011. JACC Cardiovasc Imaging. 2009. PMID: 19909933
-
Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.JACC Cardiovasc Imaging. 2017 May;10(5):526-537. doi: 10.1016/j.jcmg.2017.02.006. Epub 2017 Apr 12. JACC Cardiovasc Imaging. 2017. PMID: 28412420
-
Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population.JACC Cardiovasc Imaging. 2013 Jan;6(1):56-63. doi: 10.1016/j.jcmg.2012.08.011. JACC Cardiovasc Imaging. 2013. PMID: 23328562
-
Technical advances and clinical applications of quantitative myocardial blood flow imaging with cardiac MRI.Prog Cardiovasc Dis. 2015 May-Jun;57(6):615-22. doi: 10.1016/j.pcad.2015.02.003. Epub 2015 Feb 26. Prog Cardiovasc Dis. 2015. PMID: 25727176 Review.
-
Clinical applications of cardiac magnetic resonance imaging.Minerva Cardioangiol. 2009 Jun;57(3):299-313. Minerva Cardioangiol. 2009. PMID: 19513011 Review.
Cited by
-
All-systolic non-ECG-gated myocardial perfusion MRI: Feasibility of multi-slice continuous first-pass imaging.Magn Reson Med. 2015 Dec;74(6):1661-74. doi: 10.1002/mrm.25752. Epub 2015 Jun 6. Magn Reson Med. 2015. PMID: 26052843 Free PMC article.
-
Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusion.J Nucl Cardiol. 2009 Jul-Aug;16(4):549-61. doi: 10.1007/s12350-009-9097-6. Epub 2009 Jun 2. J Nucl Cardiol. 2009. PMID: 19488826
-
Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using a quantitative evaluation.Int J Cardiovasc Imaging. 2013 Oct;29(7):1527-36. doi: 10.1007/s10554-013-0250-6. Epub 2013 Jun 6. Int J Cardiovasc Imaging. 2013. PMID: 23739813 Clinical Trial.
-
[Indications for magnetic resonance imaging in Internal Medicine. When do we really need this technology?].Internist (Berl). 2010 Apr;51(4):451-62. doi: 10.1007/s00108-009-2452-5. Internist (Berl). 2010. PMID: 20195563 Review. German.
-
Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography.J Nucl Cardiol. 2013 Oct;20(5):860-70; quiz 857-9, 871-3. doi: 10.1007/s12350-013-9762-7. Epub 2013 Jul 19. J Nucl Cardiol. 2013. PMID: 23868071 Free PMC article. Review.
References
-
- Wischgoll T, Meyer J, Kaimovitz B, et al. A novel method for visualization of entire coronary arterial tree. Ann Biomed Eng. 2007;35:694–710. - PubMed
-
- Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506–510. - PubMed
-
- Worthley SG, Helft G, Fayad ZA, et al. Cardiac gated breath-hold black blood MRI of the coronary artery wall: an in vivo and ex vivo comparison. Int J Cardiovasc Imaging. 2001;17:195–201. - PubMed
-
- Maintz D, Ozgun M, Hoffmeier A, et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J. 2006;27:1732–1736. - PubMed
-
- Bassingthwaigthe JB, Raymond GR, Chan JIS. Principles of tracer kinetics. In: Zaret BL, Beller GA, editors. Nuclear cardiology: state of the art and future directions. St. Louis: Mosby-Year Book; 1993. pp. 3–23.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous